Latest News in the pharma Industry

Research & Development

To produce biopharmaceuticals on demand, just add water

To produce biopharmaceuticals on demand, just add water

22 Sep 2016

Freeze-dried cellular components can be rehydrated to churn out useful proteins.

Read more 
Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs

Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs

22 Sep 2016

Results published in the New England Journal of Medicine demonstrate that KAF156 shows activity against blood and liver stages of malaria parasites, including artemisinin-resistant parasites.

Read more 
EMA validates BMS’s type II variation application for Opdivo in advanced form of bladder cancer

EMA validates BMS’s type II variation application for Opdivo in advanced form of bladder cancer

20 Sep 2016

Extends the current indications for Opdivo to include the treatment of locally advanced unresectable or metastatic urothelial carcinoma in adults after failure of prior platinum-containing therapy.

Read more 
Optibrium and The Edge collaborate to integrate StarDrop with BioRails platforms

Optibrium and The Edge collaborate to integrate StarDrop with BioRails platforms

20 Sep 2016

Combination provides an enterprise platform for comprehensive data management, analysis and compound design in drug discovery.

Read more 
Heparan sulfate antibodies applications guide

Heparan sulfate antibodies applications guide

20 Sep 2016

New 24-page guide that brings together applications, protocols, results and citations for researchers.

Read more 
Gene therapy technique may help prevent cancer metastasis

Gene therapy technique may help prevent cancer metastasis

19 Sep 2016

Gene-regulating RNA molecules could help treat early-stage breast cancer tumours before they spread.

Read more 
Osteoarthritis space set to undergo radical changes, approaching $10.5 billion by 2024

Osteoarthritis space set to undergo radical changes, approaching $10.5 billion by 2024

19 Sep 2016

Current R&D strategies in osteoarthritis are characterized by a trend towards developing new analgesics with novel MOAs, and drugs with disease-modifying effects.

Read more 
FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

19 Sep 2016

Approval given to EXONDYS 51 (eteplirsen) as a once weekly intravenous infusion of 30 mg/kg for the treatment of DMD in patients who have a confirmed mutation in the DMD gene that is amenable to exon 51 skipping.

Read more 
Phase III combination trial of Bydureon and Farxiga shows significant blood sugar reduction in patients with type 2 diabetes

Phase III combination trial of Bydureon and Farxiga shows significant blood sugar reduction in patients with type 2 diabetes

18 Sep 2016

This was the first clinical trial to combine these two different anti-diabetes medicines, a GLP-1 receptor agonist and an SGLT-2 inhibitor, as an addition to standard-of-care therapy to evaluate potential benefits for patients with type 2 diabetes with...

Read more 
GSK's candidate shingles vaccine shows high efficacy against shingles

GSK's candidate shingles vaccine shows high efficacy against shingles

15 Sep 2016

Company expects to start submitting regulatory applications for the candidate vaccine for the prevention of shingles in people 50 years and above later this year.

Read more 
High-capacity nanoparticle for targeted cancer therapy

High-capacity nanoparticle for targeted cancer therapy

15 Sep 2016

MIT chemists have now shown they can package three or more drugs into a novel type of nanoparticle, allowing them to design custom combination therapies for cancer.

Read more 
AmpliPhi Biosciences’ bacteriophage cocktail shown to prevent C. difficile biofilm formation and reduce colonization

AmpliPhi Biosciences’ bacteriophage cocktail shown to prevent C. difficile biofilm formation and reduce colonization

13 Sep 2016

The data support the company's phage cocktails products' great potential as effective therapies to treat antibiotic resistant and difficult-to-treat infections.

Read more